吞功能的特点在零星包容体肌炎:初步证据使用经过充分测试的评估框架
Kevin Renz Ambrocio1, Rohit Aggarwal2,3, David Lacomis4,5
1Department of Communication Science and Disorders, School of Health and Rehabilitation Sciences, University of Pittsburgh, PA.
American journal of speech-language pathology
|October 11, 2024
概括
Sporadic Inclusion Body Myositis (IBM) 严重影响吞,特别是喉功能,影响口服摄入. 像MBSImP和FOIS这样的标准化评估对于理解和管理IBM患者的吞困难至关重要.
科学领域:
- 神经学 神经学
- 胃肠病学 胃肠病学
- 语音语言病理学 语言病理学
背景情况:
- 吞障碍是 Sporadic Inclusion Body Myositis (IBM) 的一个重要问题.
- 以前的证据依赖于非标准化和未经验证的评估方法.
- 需要强大的框架来评估IBM中的吞功能.
研究的目的:
- 通过使用验证的评估工具,调查IBM对吞功能和口服摄入的影响.
- 在IBM队列中,分析吞功能的随时间变化.
- 为了确定年龄,性别和吞障碍严重程度对口服状态的影响.
主要方法:
- 修改巴吞障碍概况 (MBSImP) 和功能性口服摄入量表 (FOIS) 数据的二次分析.
- 在13名IBM患者和13名年龄/性别匹配的健康对照人群中,吞得分的比较.
- 对IBM患者的重复测量分析和人口统计/吞变量与口服摄入的相关性.
主要成果:
- 与对照组相比,IBM患者的整体吞 (MBSImP OI) 和喉 (PT) 功能较差,口服摄入量较低 (FOIS).
- 虽然整体吞随着时间的推移显示出变化,但特定的口腔 (OT) 和喉 (PT) 组成部分没有显著恶化.
- 年龄,性别和口腔/喉损伤严重程度无法预测IBM患者口服状态.
结论:
- 喉吞障碍在IBM中突出,对口服摄入产生负面影响.
- 该研究证明了标准化评估 (MBSImP,FOIS) 对IBM吞研究的有用性.
- 这些经过验证的方法提高了对研究IBM相关的食障碍的研究的标准化和可比性.
相关概念视频
Myasthenia Gravis: Diagnostic Tests
686
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
686
Myasthenia Gravis: Overview and Treatment
1.2K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.2K


